Please use this identifier to cite or link to this item:
Title: Can type 2 diabetic serum alter macrophage phenotype
Authors: Lim, Jia Ying Tanoto
Keywords: DRNTU::Science::Medicine
Issue Date: 2017
Abstract: Inflammation, caused by obesity and metabolic changes, contributes to the pathogenesis of Type 2 diabetes (T2D) via many mechanisms and may be mediated by circulating cytokines and inflammatory markers produced by macrophages and other inflammatory cells. However, previous research has focused on specific players presumed to trigger the inflammation, such as fatty acids and high glucose, and the phenotype of macrophages when exposed to diabetic serum itself remains unclear. In this project, mouse macrophages (RAW264.7) were exposed for 16h to serum from either diabetic or normoglycemic subjects, and their M1 and M2 gene expression analysed using quantitative PCR to determine any changes in macrophage phenotype. Results showed that there was a trend towards M1 phenotype in macrophages exposed to diabetic serum, although this was not statistically significant and limited by small sample size (n=5). Further elucidation of the phenotype of macrophages may help in the understanding of the pathogenesis of T2D and development of potential drug targets towards the underlying β-cell loss in T2D from inflammation.
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:LKCMedicine Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
  Restricted Access
463 kBAdobe PDFView/Open

Page view(s)

Updated on May 18, 2021


Updated on May 18, 2021

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.